Production (Stage)
GoodRx Holdings, Inc.
GDRX
$3.74
-$0.08-2.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.21% | 1.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.21% | 1.71% | |||
| Cost of Revenue | 9.60% | 4.36% | |||
| Gross Profit | 1.73% | 1.54% | |||
| SG&A Expenses | 13.14% | -15.99% | |||
| Depreciation & Amortization | 9.51% | 8.90% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.46% | -8.46% | |||
| Operating Income | -27.89% | 88.84% | |||
| Income Before Tax | 46.10% | 40.64% | |||
| Income Tax Expenses | 20.28% | 12.59% | |||
| Earnings from Continuing Operations | 63.98% | 69.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 63.98% | 69.99% | |||
| EBIT | -27.89% | 88.84% | |||
| EBITDA | 16.31% | 10.36% | |||
| EPS Basic | 64.41% | 70.19% | |||
| Normalized Basic EPS | -33.27% | 209.52% | |||
| EPS Diluted | 64.41% | 77.00% | |||
| Normalized Diluted EPS | -33.01% | 215.85% | |||
| Average Basic Shares Outstanding | -0.63% | 0.51% | |||
| Average Diluted Shares Outstanding | -1.02% | -1.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||